JP Patent

JP7599014B2 — グアニル酸シクラーゼｃ（ｇｕｃｙ２ｃ）アゴニストおよび短鎖脂肪酸またはそのプロドラッグの組み合わせを含む医薬組成物

Assigned to Ocvirk Soren · Expires 2024-12-12 · 1y expired

What this patent protects

Patent listed against Trulance.

Drugs covered by this patent

Trulance (PLECANATIDE) · Salix

Patent Metadata

Patent number: JP7599014B2
Jurisdiction: JP
Classification: —
Expires: 2024-12-12
Drug substance claim: No
Drug product claim: No
Assignee: Ocvirk Soren
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.